34 companies filed H-1B applications for Principal Research Associate roles (through FY2026), ranked by filing volume from U.S. Department of Labor disclosure data.
| # | Employer | H-1B filings | Avg. wage |
|---|---|---|---|
| 1 | Sana Biotechnology | 12 | $103,942 |
| 2 | CRISPR Therapeutics, Inc. | 7 | $118,540 |
| 3 | Lawrence Berkeley National Laboratory | 5 | $88,886 |
| 4 | Genzyme Corporation | 4 | $74,548 |
| 5 | City Therapeutics, Inc. | 4 | $118,000 |
| 6 | TScan Therapeutics, Inc. | 4 | $105,248 |
| 7 | Ideaya Biosciences Inc. | 4 | $102,421 |
| 8 | Voyager Therapeutics | 3 | $116,449 |
| 9 | Editas Medicine, Inc | 3 | $79,023 |
| 10 | ACT Inc | 2 | $87,064 |
| 11 | Alloy Therapeutics LLC | 2 | $81,000 |
| 12 | Arbor Biotechnologies, Inc. | 2 | $110,232 |
| 13 | Cyteir Therapeutics, Inc. | 2 | $95,000 |
| 14 | Foghorn Therapeutics | 2 | $105,851 |
| 15 | GC Therapeutics, Inc. | 2 | $110,000 |
| 16 | ModernaTX, Inc. | 2 | $96,242 |
| 17 | ReNAgade Therapeutics Management Inc. | 2 | $109,116 |
| 18 | IMMUNOGEN, INC. | 1 | $85,000 |
| 19 | Land Therapeutics, Inc | 1 | $107,120 |
| 20 | Cystic Fibrosis Foundation | 1 | $80,000 |
| 21 | Viska Bio, Inc. | 1 | $93,500 |
| 22 | Mote Therapeutics Inc. | 1 | $97,000 |
| 23 | NILO Therapeutics, Inc. | 1 | $118,000 |
| 24 | Nuvation Bio | 1 | $105,000 |
| 25 | Calico Life Sciences LLC | 1 | $146,000 |
| State | H-1B filings |
|---|---|
| Massachusetts | 58 |
| California | 15 |
| New York | 3 |
| Iowa | 2 |
| New Jersey | 1 |
Counts are H-1B Labor Condition Applications (LCAs) from public U.S. Department of Labor disclosure data, whatever their outcome (certified, denied or withdrawn). Wages shown are the offered annual wage on the filing, not a guarantee of pay.